Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

Survival in Patients with Primary Pulmonary Hypertension

1991 • 3,369 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

Inhaled Iloprost for Severe Pulmonary Hypertension

2002 • 1,760 citations

The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

1992 • 1,541 citations

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

2002 • 1,383 citations

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension

2002 • 1,382 citations

Survival in Primary Pulmonary Hypertension

2002 • 1,192 citations

Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

2005 • 1,135 citations

Primary pulmonary hypertension: natural history and the importance of thrombosis.

1984 • 1,077 citations

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

2000 • 1,051 citations

Survival with first-line bosentan in patients with primary pulmonary hypertension

2005 • 611 citations

Littérature commentée

1996 • 431 citations

Introduction

2004 • 308 citations

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension

2006 • 301 citations

Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension

2006 • 290 citations

Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension

2003 • 230 citations

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

2005 • 223 citations

Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension

2005 • 222 citations

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension

2005 • 164 citations

"Survival with first-line bosentan in patients with primary pulmonary hypertension". V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galie, M. Rainisio, G. Simonneau, and L. J. Rubin. Eur Respir J 2005; 25: 244-249.

2005 • 69 citations

Introduction: new insights into a challenging disease

2004 • 50 citations

The pharmacokinetics and pharmacodynamics of the prostacyclin analog 15AU81 in the anesthetized beagle dog

1993 • 38 citations

The effects of 15AU81, a chemically stable prostacyclin analog, on the cardiovascular and renin-angiotensis systems of anesthetized dogs

1991 • 36 citations

Panel List

2004 • 14 citations